Home/Filings/4/0001608023-14-000003
4//SEC Filing

BIO-TECHNE Corp 4

Accession 0001608023-14-000003

$TECHCIK 0000842023operating

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 10:57 AM ET

Size

9.0 KB

Accession

0001608023-14-000003

Insider Transaction Report

Form 4
Period: 2014-12-01
Gavin Robert M.
Sen. VP Protein Platforms
Transactions
  • Award

    Stock Option

    2014-12-01+5,0005,000 total
    Exercise: $90.25From: 2015-12-01Exp: 2021-11-30Common Stock (5,000 underlying)
Holdings
  • Stock Option

    Exercise: $93.32From: 2015-07-31Exp: 2021-07-31Common Stock (10,000 underlying)
    10,000
  • Common Stock

    5,000
  • Stock Option

    Exercise: $93.32From: 2017-01-01Exp: 2021-07-31Common Stock (50,000 underlying)
    50,000
Footnotes (4)
  • [F1]Includes 5,000 restricted stock units that represent a contingent right to receive one share of Bio-Techne Corporation common stock. The restricted stock units vest if certain performance goals are achieved for calendar 2016.
  • [F2]Vests 2,500 on each of 07/31/2015, 07/31/2016, 07/31/2017, and 07/31/2018.
  • [F3]Includes 50,000 common stock options. The options vest if certain performance goals are achieved for calendar 2016.
  • [F4]Vests 1,250 on each of 12/01/2015, 12/01/2016, 12/01/2017, and 12/01/2018.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000842023

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 10:57 AM ET
Size
9.0 KB